Medical equipment depreciation life is the number of years an institution uses to spread a piece of purchased equipment’s capitalized cost across its expected service period. It is the input number a finance or procurement office needs before it can build a capital budget, justify an imaging-equipment purchase on a return-on-investment (ROI) basis, or set a replacement-reserve schedule — and it is genuinely two different numbers, not one, because the tax life the IRS assigns and the book life an institution’s own accounting policy assigns rarely match. This guide covers both, how they differ, what actually drives useful life for imaging and other capital medical equipment, and where to find the reference tables finance offices actually use instead of guessing.
For the mechanics of how a depreciation figure gets calculated once a useful life is set — depreciable cost, method, period-by-period allocation — see Capital Equipment Depreciation Schedule. This guide focuses specifically on the useful-life number itself: where it comes from, why tax and book life diverge, and how it feeds a capital-purchase decision.
Why depreciation life matters before you buy
Depreciation life is not just an accounting formality applied after a purchase closes — it is one of the numbers that determines whether a piece of equipment clears a capital-budgeting threshold in the first place. A shorter useful life spreads the same purchase price over fewer years, producing a larger annual depreciation charge, a higher effective annual cost of ownership, and a shorter runway before the equipment needs to reappear in next year’s capital request. For core facilities and hospital departments that recover equipment cost through a per-use service rate, depreciation life directly sets how many years that recovery has to be spread across — get it wrong and the rate either overcharges users or fails to fund the eventual replacement. For a straight purchase decision, useful life is also the denominator in most equipment ROI and total-cost-of-ownership calculations: the same annual clinical or research revenue divided by a 5-year life looks very different from the same revenue divided by a 10-year life.
Two different “lives”: tax depreciation vs. book (GAAP) useful life
Institutions buying medical equipment are almost always tracking two separate depreciation-life numbers at once, and conflating them is the most common source of confusion:
- Tax depreciation life (MACRS). For US federal income tax purposes, the Modified Accelerated Cost Recovery System (MACRS) assigns each type of property a recovery period drawn from IRS-published asset class tables (IRS Publication 946, Appendix B, built on the class lives in Rev. Proc. 87-56). This is a fixed, IRS-defined period used to compute the tax depreciation deduction — it is not a judgment call the institution makes, and it can differ from how long the equipment is actually expected to remain in service. Exact asset-class assignment depends on the specific type of equipment and how the institution is organized (for-profit hospital, tax-exempt health system, or a university/nonprofit research institution, which may not be depreciating for federal tax purposes at all); confirm the applicable class and any current-year bonus-depreciation or Section 179 provisions with a tax advisor or the current edition of Publication 946 rather than assuming a figure carries over unchanged year to year, since bonus-depreciation percentages in particular have changed repeatedly in recent tax years.
- Book / GAAP useful life. For financial statements, indirect-cost rate proposals, and (for most research institutions and nonprofit hospitals) cost accounting under 2 CFR 200.436, depreciation follows generally accepted accounting principles (GAAP) and the institution’s own written capitalization and depreciation policy — not the IRS tax-life table. Institutional policy sets this life based on the equipment’s realistic expected service period, and for hospital and clinical equipment specifically, finance offices commonly benchmark it against the American Hospital Association’s Estimated Useful Lives of Depreciable Hospital Assets guide (published in partnership with the American Society for Health Care Engineering, ASHE, and periodically revised), which assigns a specific estimated useful life to individual equipment categories. Book useful life is usually longer than tax life for the same asset, because MACRS recovery periods are deliberately accelerated as a tax incentive, not designed to match real-world service life.
Because these two numbers serve different purposes and different audiences (a tax return vs. a financial statement, an indirect-cost proposal, or a service-rate worksheet), most institutions track both for the same physical asset rather than trying to reconcile them into one figure.
Where the actual numbers come from
CASRAI does not publish a universal table of “X years for this model of scanner” — and be skeptical of any source that does without citing where its numbers come from, since useful life legitimately varies by institutional policy, equipment configuration, and duty cycle. The two reference sources finance and procurement offices actually rely on are:
- For tax life: IRS Publication 946’s Appendix B asset class tables (Table B-1 for general categories, Table B-2 for activity-specific categories), which assign a MACRS recovery period by asset class rather than by brand or model.
- For book/GAAP life on hospital and clinical equipment: the AHA/ASHE Estimated Useful Lives of Depreciable Hospital Assets guide, which is the standard industry reference for benchmarking institutional depreciation policy on categories from major diagnostic imaging systems down to general patient-care equipment, and is revised periodically to reflect changes in typical equipment life.
An institution’s own written capitalization policy should specify which reference it uses (or its own internally-set schedule) and should be applied consistently across equipment of the same type — both to satisfy GAAP consistency and, for federally sponsored research equipment, to meet the consistency requirement in 2 CFR 200.436.
What actually shortens useful life for imaging and other medical equipment
The accounting useful-life figure is a planning estimate, not a guarantee, and several factors specific to imaging and other high-value medical equipment routinely force earlier real-world replacement even when the depreciation schedule isn’t finished:
- Manufacturer end-of-service-life and parts availability. Once a manufacturer discontinues parts support or software updates for a given imaging platform, continued clinical or research use becomes a risk-management question independent of the depreciation schedule.
- Technology and clinical-standard obsolescence. Imaging modalities in particular see meaningful resolution, dose, and software capability improvements between generations; a scanner that is only two-thirds depreciated can still become functionally obsolete for current clinical or research protocols.
- Utilization intensity. Equipment run near-continuously wears mechanically faster than the same model on a light duty cycle, even though both follow the same depreciation schedule on paper.
- Regulatory and calibration requirements. Equipment subject to periodic recertification (radiation-producing imaging equipment, for example) can face a real service-life ceiling set by inspection or licensing requirements rather than accounting policy.
- Service contract economics. As equipment ages past its useful life, extended-warranty and service-contract costs typically rise sharply, which is itself a data point finance offices weigh in replacement-vs-repair decisions.
A capital-planning process that only tracks the accounting depreciation life risks being caught off guard by any of these; mature equipment-management programs track both figures side by side. See Laboratory Asset Management Software for how institutions track equipment condition and lifecycle status alongside the depreciation schedule itself.
How depreciation life feeds the purchase decision
Before committing capital to a new piece of medical equipment, depreciation life feeds directly into at least three decisions:
- Capital budgeting and replacement reserves. Annual depreciation expense (capitalized cost minus salvage value, divided by useful life under the straight-line method most institutions use) is the figure that typically funds a replacement reserve — if the reserve isn’t accumulating at that rate, the institution is effectively deferring a future capital gap rather than funding it.
- Lease-vs-purchase analysis. A shorter useful life makes ownership less attractive relative to leasing, because the same purchase price gets recovered (for accounting purposes) faster but the institution also loses residual value sooner. See Lease vs. Purchase Analysis for Federally Funded Equipment for how this plays out specifically under 2 CFR 200.465 when the purchase involves federal award funds.
- ROI and total-cost-of-ownership modeling. Most equipment ROI calculations divide expected clinical, research, or cost-savings value by the equipment’s useful life to get an annualized return; using an unrealistically long useful life in that calculation (versus what the equipment will actually deliver before real-world obsolescence, as covered above) is a common way ROI projections overstate a purchase’s attractiveness.
Worked example
The figures below are an illustrative calculation, not a published benchmark for any specific equipment model — use it to see how the two “lives” produce two different numbers for the same asset, not as a number to copy into a real budget.
An institution buys a diagnostic imaging system for $500,000 installed, with an estimated $20,000 salvage value. Its written capitalization policy, benchmarked against the AHA/ASHE useful-life guide for that equipment category, assigns an 8-year book useful life. Under straight-line depreciation, book depreciation expense is ($500,000 − $20,000) ÷ 8 = $60,000 per year for financial-statement and cost-accounting purposes.
For federal tax purposes, the same asset might fall into a MACRS asset class with, say, a 5-year GDS recovery period — producing a materially different (and front-loaded, under MACRS’s declining-balance convention for most property classes) tax depreciation deduction in early years compared to the flat $60,000/year book figure. The institution tracks both: the book figure feeds its financial statements, indirect-cost proposal, and replacement-reserve planning; the tax figure (where applicable) feeds its tax return. Neither number substitutes for the other, and neither is “the” depreciation life of the equipment — there are two, by design.
Frequently asked questions
Is medical equipment 5-year or 7-year property for tax depreciation?
It depends on the specific asset class the equipment is assigned to under IRS Publication 946’s tables, and on whether the owning entity is a taxable business, a tax-exempt hospital, or a nonprofit/university research institution not subject to federal income tax depreciation at all. Don’t assume a single blanket answer applies to every piece of equipment — confirm the applicable MACRS class (and any current bonus-depreciation or Section 179 election, both of which change year to year) with a tax advisor or current IRS guidance before relying on a specific recovery period.
Do hospitals and universities depreciate equipment the same way?
Both follow GAAP for book/financial-statement purposes, and both typically use straight-line depreciation for that purpose. Where they diverge is federal tax treatment (most nonprofit hospitals and universities aren’t computing MACRS tax depreciation the way a taxable business does) and in which reference guide informs the useful-life estimate — hospitals commonly benchmark clinical equipment against the AHA/ASHE useful-life guide, while a university research core facility is more likely to be governed primarily by 2 CFR 200.436 and its own institutional capitalization policy. See Capital Equipment for the capitalization threshold question that determines whether an asset gets depreciated at all.
What happens once equipment is fully depreciated but still in use?
The equipment stays on the fixed-asset register at its (typically zero, or salvage-value) net book value and continues to be used with no further depreciation expense recognized, until it is formally retired or disposed of. It’s a common and expected state, not an error — plenty of equipment remains clinically or scientifically useful well past the end of its accounting useful life. See Asset Disposal Policy for Lab Equipment for how the eventual retirement of that asset should be documented.
Where can I find a published useful-life table instead of estimating my own?
For tax life, IRS Publication 946’s Appendix B tables (Table B-1 and B-2). For book/GAAP life on hospital and clinical equipment specifically, the AHA/ASHE Estimated Useful Lives of Depreciable Hospital Assets guide is the standard industry reference. Either way, the institution’s own written capitalization policy should specify which source it follows and apply it consistently, rather than setting useful life case by case.
